Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Recent advances in understanding and preventing human papillomavirus-related disease.

Hellner K, Dorrell L.

F1000Res. 2017 Mar 14;6. pii: F1000 Faculty Rev-269. doi: 10.12688/f1000research.9701.1. eCollection 2017. Review.

2.

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.

Rozemeijer K, Naber SK, Penning C, Overbeek LI, Looman CW, de Kok IM, Matthijsse SM, Rebolj M, van Kemenade FJ, van Ballegooijen M.

BMJ. 2017 Feb 14;356:j504. doi: 10.1136/bmj.j504.

3.

VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.

Xie Y, Tan X, Shao H, Liu Q, Tou J, Zhang Y, Luo Q, Xiang Q.

BMC Public Health. 2017 Jan 25;17(1):118. doi: 10.1186/s12889-017-4054-9.

4.

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.

Simms KT, Hall M, Smith MA, Lew JB, Hughes S, Yuill S, Hammond I, Saville M, Canfell K.

PLoS One. 2017 Jan 17;12(1):e0163509. doi: 10.1371/journal.pone.0163509. eCollection 2017.

5.

A comparison of liquid-based cytology with conventional Papanicolaou smears in cervical dysplasia diagnosis.

Haghighi F, Ghanbarzadeh N, Ataee M, Sharifzadeh G, Mojarrad JS, Najafi-Semnani F.

Adv Biomed Res. 2016 Oct 26;5:162. eCollection 2016.

6.

Comparison of the Cervex-Brush® Combi and the Cytobrush+Ayres Spatula Combination for Cervical Sampling in Liquid-Based Cytology.

Simonsen M, Tavares Guerreiro Fregnani JH, Possati Resende JC, Antoniazzi M, Longatto-Filho A, Scapulatempo-Neto C.

PLoS One. 2016 Oct 14;11(10):e0164077. doi: 10.1371/journal.pone.0164077. eCollection 2016.

7.

Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR.

Chanthavilay P, Reinharz D, Mayxay M, Phongsavan K, Marsden DE, Moore L, White LJ.

PLoS One. 2016 Sep 15;11(9):e0162915. doi: 10.1371/journal.pone.0162915. eCollection 2016.

8.

Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing.

Pedersen K, Burger EA, Sy S, Kristiansen IS, Kim JJ.

Gynecol Oncol. 2016 Nov;143(2):326-333. doi: 10.1016/j.ygyno.2016.08.231. Epub 2016 Aug 17.

PMID:
27542966
9.

Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2.

Guenat D, Launay S, Riethmuller D, Mougin C, Prétet JL.

Infect Agent Cancer. 2016 Aug 17;11:41. doi: 10.1186/s13027-016-0092-7. eCollection 2016.

10.

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.

Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Srisomboon J, Intaraphet S, Siriaunkgul S.

PLoS One. 2016 Jun 23;11(6):e0158184. doi: 10.1371/journal.pone.0158184. eCollection 2016.

11.

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand.

Lew JB, Simms K, Smith M, Lewis H, Neal H, Canfell K.

PLoS One. 2016 May 17;11(5):e0151619. doi: 10.1371/journal.pone.0151619. eCollection 2016.

12.

Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines.

Burger EA, Lee K, Saraiya M, Thompson TD, Chesson HW, Markowitz LE, Kim JJ.

Cancer. 2016 Jul 1;122(13):2057-66. doi: 10.1002/cncr.30007. Epub 2016 Apr 28.

13.

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.

Boers A, Wang R, van Leeuwen RW, Klip HG, de Bock GH, Hollema H, van Criekinge W, de Meyer T, Denil S, van der Zee AGJ, Schuuring E, Wisman GBA.

Clin Epigenetics. 2016 Mar 9;8:29. doi: 10.1186/s13148-016-0196-3. eCollection 2016.

14.

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.

Rozemeijer K, Penning C, Siebers AG, Naber SK, Matthijsse SM, van Ballegooijen M, van Kemenade FJ, de Kok IM.

Cancer Causes Control. 2016 Jan;27(1):15-25. doi: 10.1007/s10552-015-0678-1. Epub 2015 Oct 12.

15.

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark.

Rebolj M, Rask J, van Ballegooijen M, Kirschner B, Rozemeijer K, Bonde J, Rygaard C, Lynge E.

Br J Cancer. 2015 Nov 3;113(9):1259-74. doi: 10.1038/bjc.2015.339. Epub 2015 Oct 8.

16.

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.

Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Ann Intern Med. 2015 Oct 20;163(8):589-97. doi: 10.7326/M15-0420. Epub 2015 Sep 29.

17.

Evaluation of hybrid algorithm for analysis of scattered light using ex vivo nuclear morphology measurements of cervical epithelium.

Ho D, Drake TK, Bentley RC, Valea FA, Wax A.

Biomed Opt Express. 2015 Jul 7;6(8):2755-65. doi: 10.1364/BOE.6.002755. eCollection 2015 Aug 1.

18.

Comparison of conventional Papanicolaou cytology samples with liquid-based cervical cytology samples from women in Pernambuco, Brazil.

Costa MO, Heráclio SA, Coelho AV, Acioly VL, Souza PR, Correia MT.

Braz J Med Biol Res. 2015 Sep;48(9):831-8. doi: 10.1590/1414-431X20154252. Epub 2015 Jul 31.

19.

Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia.

Park IU, Wojtal N, Silverberg MJ, Bauer HM, Hurley LB, Manos MM.

PLoS One. 2015 Mar 20;10(3):e0118938. doi: 10.1371/journal.pone.0118938. eCollection 2015.

20.

Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.

Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC; HERMES study group.

PLoS One. 2015 Mar 20;10(3):e0119755. doi: 10.1371/journal.pone.0119755. eCollection 2015.

Supplemental Content

Support Center